Oncology digital twins to support drug development decision-making.
License protocol-aligned oncology cohorts, explore outcomes in the Evinexus evidence platform, and apply the evidence to trial design and comparator strategies.
Protocol-aligned cohort
Advanced solid tumor · 2L+
Award-winning evidence
Global Scrip Award (2018) — Best Use of Real-World Evidence
21 / 21
Estimate agreement with published trial results
30–50%
Fewer control patients (external-control simulations)
~3.1 yrs
Follow-up removed in the emulation
What is a digital twin?
A patient-level representation aligned to a defined study question.
Evinexus combines harmonized oncology data, physician-led curation, and validation to produce patient-level cohorts aligned to your protocol and evidence question.
Each cohort includes defined endpoints, documented provenance, and a stated intended use.
See the digital twin solutionFoundation
Oncology data
Longitudinal clinical variables, treatment, and outcomes.
Evinexus
Twin cohort
Curated, validated, protocol-aligned patients.
Application
Decision evidence
Control arms, trial design, and development strategy.
What Evinexus delivers
Digital twin data and a platform to use it.
With Evinexus, sponsors can minimize the coordination needed across separate data sources to answer your research question.
Contact usDigital Twin Data
Patient-level oncology cohorts scoped to the indication, eligibility criteria, endpoints, follow-up, and intended study question.
Evidence Platform
A workspace for examining cohort characteristics, comparing outcomes, and reviewing scenario assumptions.
Evinexus scientists support feasibility, study design, analysis, and interpretation.
Applications
Apply digital twins across trial design and evidence generation.
External control arms
Build a protocol-aligned comparator when a concurrent control is infeasible or impractical.
Learn how it worksHybrid control arms
Supplement a smaller randomized control with prespecified external evidence.
Learn how it worksTrial and program decisions
Assess feasibility, population assumptions, endpoints, and development scenarios before committing the study design.
Learn how it worksValidation
Tested against published Phase 3 trial results.
Evinexus has evaluated whether digital twin cohorts reproduce published treatment and control estimates in landmark Phase 3 trials. Review the endpoint-level comparisons, regulatory context, and limitations on the Evidence page.
Assess whether digital twins fit your study.
Share the indication, population, endpoint, and intended use. Evinexus will review whether the available data can support the question.